The role of IL-6/JAK2/STAT3 signaling pathway in cancers

B Huang, X Lang, X Li - Frontiers in oncology, 2022 - frontiersin.org
Interleukin-6 (IL-6) is a pleiotropic cytokine involved in immune regulation. It can activate
janus kinase 2 (JAK2)-signal transducer and activator of transcription 3 (STAT3) signaling …

Revisiting STAT3 signalling in cancer: new and unexpected biological functions

H Yu, H Lee, A Herrmann, R Buettner, R Jove - Nature reviews cancer, 2014 - nature.com
Abstract The Janus kinases (JAKs) and signal transducer and activator of transcription
(STAT) proteins, particularly STAT3, are among the most promising new targets for cancer …

Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma

R Salam, A Saliou, F Bielle, M Bertrand… - Nature …, 2023 - nature.com
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, yet it
remains refractory to systemic therapy. Elimination of senescent cells has emerged as a …

STAT3 activation-induced fatty acid oxidation in CD8+ T effector cells is critical for obesity-promoted breast tumor growth

C Zhang, C Yue, A Herrmann, J Song, C Egelston… - Cell metabolism, 2020 - cell.com
Although obesity is known to be critical for cancer development, how obesity negatively
impacts antitumor immune responses remains largely unknown. Here, we show that …

A three-dimensional organoid culture system derived from human glioblastomas recapitulates the hypoxic gradients and cancer stem cell heterogeneity of tumors …

CG Hubert, M Rivera, LC Spangler, Q Wu… - Cancer …, 2016 - aacrjournals.org
Many cancers feature cellular hierarchies that are driven by tumor-initiating cancer stem
cells (CSC) and rely on complex interactions with the tumor microenvironment. Standard cell …

Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis

M Wu, X Zhang, W Zhang, YS Chiou, W Qian… - Nature …, 2022 - nature.com
Cancer cells display phenotypic equilibrium between the stem-like and differentiated states
during neoplastic homeostasis. The functional and mechanistic implications of this …

Drug resistance in glioblastoma: the two faces of oxidative stress

C Olivier, L Oliver, L Lalier, FM Vallette - Frontiers in molecular …, 2021 - frontiersin.org
Glioblastomas (GBM) are the most common primary brain tumor with a median survival of 15
months. A population of cells with stem cell properties (glioblastoma stem cells, GSCs) …

The adaptive transition of glioblastoma stem cells and its implications on treatments

Z Wang, H Zhang, S Xu, Z Liu, Q Cheng - Signal transduction and …, 2021 - nature.com
Glioblastoma is the most malignant tumor occurring in the human central nervous system
with overall median survival time< 14.6 months. Current treatments such as chemotherapy …

Tumor-related interleukins: old validated targets for new anti-cancer drug development

S Setrerrahmane, H Xu - Molecular cancer, 2017 - Springer
In-depth knowledge of cancer molecular and cellular mechanisms have revealed a strong
regulation of cancer development and progression by the inflammation which orchestrates …

Cancer stem cells in glioblastoma

JD Lathia, SC Mack, EE Mulkearns-Hubert… - Genes & …, 2015 - genesdev.cshlp.org
Tissues with defined cellular hierarchies in development and homeostasis give rise to
tumors with cellular hierarchies, suggesting that tumors recapitulate specific tissues and …